The global pharmaceutical landscape is currently navigating a period of intense transformation, defined by high-stakes clinical outcomes,...
Chemotherapy and Targeted Therapy
BioMarin’s Strategic Expansion: Alesta Acquisition Signals Pivot Toward Broader Rare Disease Markets
BioMarin’s Strategic Expansion: Alesta Acquisition Signals Pivot Toward Broader Rare Disease Markets
By Jonathan Gardner | August 18, 2026 In a move that underscores its aggressive pursuit of clinical-stage...
The landscape of breast cancer care is undergoing a seismic shift. As clinical evidence mounts regarding the...
PharmSci 360 2026: A Landmark Collaboration Between AAPS and USP to Shape the Future of Drug Quality
PharmSci 360 2026: A Landmark Collaboration Between AAPS and USP to Shape the Future of Drug Quality
The global pharmaceutical landscape is currently undergoing a period of profound transformation, characterized by the rapid emergence...
By Jonathan Gardner | Published August 17, 2026 In a significant blow to its aggressive long-term growth...
In a landmark shift for the pharmaceutical industry, Schrödinger, the pioneer of physics-based computational drug discovery, has...
In a stark reminder of the volatility inherent in the biotechnology sector, EyePoint Pharmaceuticals saw nearly $1...
In a move set to reshape the landscape of oral drug delivery, AustinPx—a Texas-based Contract Development and...
As the pharmaceutical industry navigates an era defined by rapid technological disruption and increasingly complex molecular targets,...
In the high-stakes environment of pharmaceutical safety, the mantra of the last decade has been "automation." From...
